The in vitro antibacterial activity of four 18-lactam antibiotics (cefatrizine 
Many of the Enterobacteriaceae, in particular strains of Enterobacter spp., Providencia spp., Serratia spp., and indole-positive Proteus spp., are resistant to cephalothin. Strains of Pseudomonas aeruginosa are uniformly resistant. This resistance pattern was noted when the drug was introduced in 1962 (19) . Subsequently, the widespread use of the cephalosporins has led to increasing resistance of some other clinical isolates to cephalothin (11) .
Cefatrizine (BL-S640) (9, 10, 17, 21) and cefamandole (5, 16) are new semisynthetic cephalosporins that have been shown to be at least as active as cephalothin in vitro against gramnegative bacilli. Cefatrizine has been shown to be active in vitro against cephalosporin-resistant strains ofEnterobacter spp., indole-positive Proteus spp., and P. stuartii (9) and to be efficacious in the treatment of experimental murine urinary tract and systemic infections caused by these same organisms (10) . Cefamandole has also been shown to be active against cephalothin-resistant strains of Enterobacter spp., indole-positive Proteus spp., and Providencia spp., (5, 16) , as well as some strains of S. marcescens (16) ; it is currently undergoing clinical investigation.
The cephamycins (18) Cefoxitin is the first'semisynthetic cephamycin that has been made available for clinical investigation. It is structurally analogous to cephalothin, but perhaps in part, because of its resistance to /8-lactamases (15) , it has been reported to be more active than cephalothin against indole-positive Proteus spp., Providencia spp., and S. marcescens (2, 8, 14, 15) , as well as some strains of Enterobacter (8, 15) . These reports of two new cephalosporins and a new family of compounds with a broader spectrum of activity than cephalothin against gram-negative rods, as well as the availability of newer aminoglycosides, provided the impetus for this study. We have determined and compared the activity of cefatrizine, cefamandole, cefoxitin, cephalothin, carbenicillin, gentamicin, amikacin, and tobramycin against cephalothin-resistant clinical isolates of Enterobacteriaceae at our hospital. We know of no other study that has compared the in vitro activity of these agents. Since cefatrizine, cefamandole, and cefoxitin have shown no activity against strains of P. aeruginosa, these organisms were not included in this study. Susceptibility to an antibiotic was based upon inhibition of strains at or below peak levels of antibiotics achieved in clinical use or in preclinical studies with volunteers. The following MICs in agar were considered as showing susceptibility: cefatrizine, c8 ,g/ml; cefamandole, c32 Ag/ml; cefoxitin, c32 ug/ml; cephalothin, -16 Ag/ml; carbenicillin, -128 ,ug/ml; gentamicin, c8 ,ug/ml; tobramycin, s8 ,ug/ml; and amikacin, l16 ,ug/ml. All determinations were made in duplicate or triplicate, and the MICs were expressed as averages.
RESULTS
During the period of this study, 197 strains of Enterobacteriaceae with disk zone sizes of -14 mm against the 30-,.g disk of cephalothin were confirmed to be cephalothin-resistant (MIC 2 32 /Ag/ml) by the ICS-WHO agar dilution method (4). Eighty strains proved to be gentamicin sensitive (MIC c 8 ug/ml), and 117 were gentamicin resistant (MIC - 16 ,ug/ml). During the initial phases of this study, we were interested primarily in collecting gentamicin-resistant organisms, so these figures do not reflect the true incidence of gentamicin resistance in our hospital (12; Meyer et al., Clin. Res.). There were appreciable differences in the activity of cefamandole, cefoxitin, carbenicillin, and tobramycin against gentamicin-sensitive as opposed to gentamicin-resistant strains. Table 1 and Fig. 1 through 3 summarize the data for the gentamicin-sensitive, cephalothin-resistant organisms. The data for the gentamicin-and cephalothin-resistant organisms are outlined in Table 2 and Fig. 4 through 7 .
Gentamicin-sensitive organisms. Seventeen strains of cephalothin-resistant S. marcescens were sensitive to gentamicin. Of the B3-lactam antibiotics studied, only carbenicillin was active against two-thirds or more of the strains. Cefatrizine had no activity at all, cefamandole had very little, and cefoxitin was active against only 35.2% of the gentamicin-sensitive S. marcescens (Table 1, Fig. 1 Eight strains ofKlebsiella spp., 15 ofE. coli, and 4 ofindole-positive Proteus spp. were sensitive to gentamicin. Since the susceptibility patterns to the antibiotics studied were similar, the data on these 27 strains were pooled. (Table  1, Fig. 3 ). Cefoxitin > cefamandole > carbenicillin were clearly superior to cephalothin, but again cefatrizine showed only minimal activity.
These 80 gentamicin-sensitive strains were Gentamicin-resistant organisms. Fifty strains ofS. marcescens accounted for over 40% of the 117 gentamicin-resistant organisms. Cefoxitin was the only /8-lactam antibiotic studied that showed any appreciable activity (12% susceptible at -32 jig/ml and 34% at -64 ug/ml).
These organisms were almost uniformly resistant to cefatrizine, cefamandole, carbenicillin, and tobramycin. Amikacin, however, was active against 96% ofthe organisms ( Table 2 , Fig.   4 ).
Cefoxitin was the most active (3-lactam antibiotic in vitro against 23 strains of Klebsiella spp. (91.3% susceptible at s32 ,g/ml). Cefamandole was active against 9.1%, but cefatrizine, carbenicillin, and tobramycin exhibited no activity whatsoever. Amikacin was effective against 100% of these strains ( Table 2 , Fig. 5 ).
The data on six E. coli, five Enterobacter spp., seven indole-positive Proteus spp., and three P. mirabilis were pooled (Table 2, Fig. 6 ). These 21 strains had similar susceptibility patterns and were all gentamicin resistant. Cefoxitin was again the most active (3-lactam antibiotic (95.2% susceptible at <32 ug/ml). Carbenicillin (23.8% susceptible) was more active than cefamandole (19.0% susceptible) and cefatrizine (4.8% susceptible). One-third of these strains were susceptible to tobramycin. All were inhibited by amikacin.
Twenty-three strains ofP. stuartii were uniformly susceptible to amikacin ( (15) , and Proteus (4). cefatrizine showed no activity. Tobramycin was active against only 30.4% of these strains. DISCUSSION Cefatrizine has a half-life in serum greater than that of cephalexin and has been shown to be superior to other cephalosporins in the treatment of gram-negative bacillary experimental systemic or urinary tract infections in mice (10) . On the basis of reasonable expectation of blood levels, our in vitro data suggest that cefatrizine cannot be expected to be very useful in treating cephalothin-resistant organisms.
Cefamandole was active against over 50% of our gentamicin-sensitive strains of Enterobacter spp., Klebsiella spp., E. coli, and indolepositive Proteus. These strains were, however, also usually sensitive to carbenicillin, as noted previously by others (16) . Cefamandole showed appreciable (73.9% susceptible) activity against P. stuartii. These organisms are not usually susceptible to carbenicillin and were not in our study (Table 2 , Fig. 7 ). Cefamandole appears to offer promise in the treatment of infections secondary to the organisms noted above.
Carbenicillin was the most active of the ,Blactam antibiotics tested against gentamicinsensitive S. marcescens and Enterobacter spp. 23:55A, 1975 ), many of our S. marcescens are resistant to both cefoxitin and carbenicillin. The mechanism of broader gram-negative antibacterial activity of cefoxitin over that of cephalothin demonstrated here and in other studies (2, 8, 14) is unclear but probably relates in part to its relative resistance to 3-lactamases (15 foxitin is most active in vitro. Cefamandole is less effective in vitro than cefoxitin against cephalothin-resistant organisms but has significant activity against some strains. With the exception of strains of P. stuartii, these are usually also sensitive to carbenicillin. Cefatrizine had little activity against the organisms studied, and its usefulness may be limited by relatively low concentrations achieved after oral administration. Amikacin was the most active antibiotic tested against our multipledrug-resistant Enterobacteriaceae.
